ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 114 filers reported holding ACCELERON PHARMA INC in Q4 2014. The put-call ratio across all filers is 0.52 and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $3,550,000 | +35.2% | 20,628 | -1.4% | 0.04% | +34.6% |
| Q2 2021 | $2,626,000 | -11.3% | 20,925 | -4.1% | 0.03% | -16.1% |
| Q1 2021 | $2,960,000 | +0.4% | 21,824 | -5.3% | 0.03% | -6.1% |
| Q4 2020 | $2,947,000 | +11.3% | 23,034 | -2.1% | 0.03% | -5.7% |
| Q3 2020 | $2,647,000 | -38.4% | 23,522 | -47.9% | 0.04% | -42.6% |
| Q2 2020 | $4,298,000 | -0.7% | 45,119 | -6.3% | 0.06% | -15.3% |
| Q1 2020 | $4,329,000 | +39.3% | 48,172 | -17.8% | 0.07% | +80.0% |
| Q4 2019 | $3,108,000 | +33.3% | 58,624 | -0.7% | 0.04% | +25.0% |
| Q3 2019 | $2,332,000 | -4.3% | 59,027 | -0.6% | 0.03% | -5.9% |
| Q2 2019 | $2,438,000 | -11.7% | 59,355 | +0.1% | 0.03% | -15.0% |
| Q1 2019 | $2,762,000 | +8.9% | 59,315 | +1.8% | 0.04% | -4.8% |
| Q4 2018 | $2,536,000 | -23.9% | 58,242 | 0.0% | 0.04% | -10.6% |
| Q3 2018 | $3,333,000 | +17.1% | 58,242 | -0.7% | 0.05% | +11.9% |
| Q2 2018 | $2,847,000 | +21.0% | 58,670 | -2.5% | 0.04% | +16.7% |
| Q1 2018 | $2,353,000 | -7.9% | 60,170 | 0.0% | 0.04% | -7.7% |
| Q4 2017 | $2,554,000 | +13.6% | 60,170 | -0.2% | 0.04% | +5.4% |
| Q3 2017 | $2,249,000 | +22.8% | 60,265 | 0.0% | 0.04% | +15.6% |
| Q2 2017 | $1,831,000 | +11.9% | 60,265 | -2.5% | 0.03% | +10.3% |
| Q1 2017 | $1,636,000 | +43.4% | 61,787 | +38.3% | 0.03% | +38.1% |
| Q4 2016 | $1,141,000 | -29.4% | 44,691 | +0.1% | 0.02% | -34.4% |
| Q3 2016 | $1,616,000 | +6.5% | 44,663 | 0.0% | 0.03% | 0.0% |
| Q2 2016 | $1,518,000 | +29.5% | 44,663 | +0.6% | 0.03% | +23.1% |
| Q1 2016 | $1,172,000 | -45.8% | 44,413 | +0.1% | 0.03% | -46.9% |
| Q4 2015 | $2,163,000 | +97.0% | 44,363 | +0.6% | 0.05% | +88.5% |
| Q3 2015 | $1,098,000 | -20.1% | 44,103 | +1.5% | 0.03% | -13.3% |
| Q2 2015 | $1,375,000 | -16.9% | 43,453 | 0.0% | 0.03% | -16.7% |
| Q1 2015 | $1,654,000 | +4252.6% | 43,453 | +3362.4% | 0.04% | +3500.0% |
| Q3 2014 | $38,000 | +22.6% | 1,255 | +39.4% | 0.00% | 0.0% |
| Q2 2014 | $31,000 | – | 900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co IV LLC | 2,803,645 | $84,782,000 | 78.57% |
| Cormorant Asset Management, LP | 400,000 | $12,096,000 | 2.49% |
| Deer VII & Co. Ltd. | 175,075 | $5,294,000 | 2.36% |
| QVT Financial LP | 1,193,258 | $36,084,000 | 1.86% |
| Foresite Capital Management I, LLC | 55,767 | $1,686,000 | 1.62% |
| Perceptive Advisors | 445,000 | $13,457,000 | 1.44% |
| SECTORAL ASSET MANAGEMENT INC | 726,424 | $21,967,000 | 0.92% |
| Iguana Healthcare Management, LLC | 25,000 | $756,000 | 0.40% |
| SPHERA FUNDS MANAGEMENT LTD. | 100,000 | $3,024,000 | 0.37% |
| Eventide Asset Management | 62,100 | $1,878,000 | 0.26% |